Guided tissue regeneration with immobilized cytokine

用固定化细胞因子引导组织再生

基本信息

  • 批准号:
    16591996
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Bone morphogenetic protein 2(BMP-2) plays an important role in bone growth and regeneration. The creation of purified recombinant human BMP-2 (rhBMP-2) has led to advances in its potential for clinical use, however this protein is soluble and disperses soon after implantation. So rhBMP-2 can't have long time stimulation to BMP signaling cascade. To overcome this problem we reported the effects of immobilization of rhBMP-2 to succinylated type I atelocollagenThe mechanism of immobilized rhBMP-2 is based on the theories of covalent bonding between rhBMP-2 and succinylated type I atelocollagen. The immobilized rhBMP-2 binds with the receptor on the cell surface without being internalized into the cell, so it is able to transduce signals into the cell over a long period of time, achieving high efficiency in promoting cell proliferation.We investigated the effect of immobilized rhBMP-2 by the way of (a) histological findings, (b) alkaline phosphatase (ALP) activity, (c) BMP intracellular signaling cascade (Smad1, Smad5 and phospho Smad1/5/8) expression, and (d) type I collagen, osteonectin, osteopontin, ostocalcin, and Smad1/5/8 mRNA expression.Our results showed that (1) nonimmobilized and immobilized rhBMP-2 also increased the alkaline phosphatase (ALP) activity in ST2, MC3T3 and C2C12 cells. However significantly higher ALP activity was observed by the immobilized rhBMP-2 treatment. (2) Phosphorylation of Smad1/5/8 after nonimmobilized rhBMP-2 stimulation increased from 15 min after stimulation and decrease to the control revel after 6hrs, however the phosphorylation was prolonged by immobilized rhBMP-2 and its effect was detectable even after 48hrs.So we conclude that because immobilized rhBMP-2 can emphasize and prolonged the effect of rhBMP-2, immobilizing rhBMP-2 is an efficient method to increase bone induction.
骨形态发生蛋白2(BMP-2)在骨生长和再生中起重要作用。纯化重组人BMP-2 (rhBMP-2)的产生在其临床应用潜力方面取得了进展,然而这种蛋白质是可溶性的,在植入后很快就会分散。因此,rhBMP-2不能对BMP信号级联产生长时间的刺激。为了克服这一问题,我们报道了固定化rhBMP-2对琥珀酰化I型间胶原的影响。固定化rhBMP-2的机制是基于rhBMP-2与琥珀酰化I型间胶原之间的共价键理论。固定化后的rhBMP-2与细胞表面的受体结合而不被内化到细胞内,因此能够在较长时间内将信号转导到细胞内,达到促进细胞增殖的高效率。我们通过(a)组织学结果,(b)碱性磷酸酶(ALP)活性,(c) BMP细胞内信号级联(Smad1, Smad5和磷酸化Smad1/5/8)表达,以及(d) I型胶原,骨连接素,骨桥蛋白,骨钙素和Smad1/5/8 mRNA表达来研究固定化rhBMP-2的影响。结果表明:(1)非固定化和固定化rhBMP-2均能提高ST2、MC3T3和C2C12细胞的碱性磷酸酶(ALP)活性。然而,固定化rhBMP-2处理显著提高了ALP活性。(2)非固定化rhBMP-2刺激后Smad1/5/8的磷酸化从刺激后15 min开始升高,6h后降至对照水平,而固定化rhBMP-2则延长了磷酸化时间,即使在48h后仍可检测到其作用。因此,由于固定化rhBMP-2可以强化和延长rhBMP-2的作用,因此固定化rhBMP-2是一种有效的增强骨诱导的方法。

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas
  • DOI:
    10.1016/j.gene.2005.02.014
  • 发表时间:
    2005-08-15
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Gunduz, M;Nagatsuka, H;Nagai, N
  • 通讯作者:
    Nagai, N
Various immunostaining patterns of CD31, CD34 and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinomas
  • DOI:
    10.1111/j.1600-0714.2004.00227.x
  • 发表时间:
    2005-02-01
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Nagatsuka, H;Hibi, K;Nagai, N
  • 通讯作者:
    Nagai, N
Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506
  • DOI:
    10.1016/j.bone.2003.05.003
  • 发表时间:
    2004-03-01
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Fukunaga, J;Yamaai, T;Sugahara, T
  • 通讯作者:
    Sugahara, T
Effects of immobilized recombinant human bone morphogenetic protein-2/succinylated type I atelocollagen on cellular activity of ST2 cells
Immobilized rhBMP-2/succinylated type I atelocollagen gene expression of intracellular signaling molecules on ST2 cells.
ST2 细胞上细胞内信号分子的固定化 rhBMP-2/琥珀酰化 I 型去端胶原基因表达。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tsukuba;T. et al.;Tsujigiwa H
  • 通讯作者:
    Tsujigiwa H
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMACHIKA Eiki其他文献

YAMACHIKA Eiki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMACHIKA Eiki', 18)}}的其他基金

Development of a treatment model for osteoporosis using an inner bone environment system
利用内部骨环境系统开发骨质疏松症治疗模型
  • 批准号:
    24593054
  • 财政年份:
    2012
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bone regeneration with osteoblast gel and artificial bone marrow which can produce interaction between stem cells
使用成骨细胞凝胶和人造骨髓进行骨再生,可以在干细胞之间产生相互作用
  • 批准号:
    21592573
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bone regeneration with bone marrow stem cell and immobilized cytokine
利用骨髓干细胞和固定化细胞因子进行骨再生
  • 批准号:
    19592296
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Development of platform for non-invasive, rapid, and simple analysis of cytokine secretion from single cells
开发非侵入、快速、简单分析单细胞细胞因子分泌的平台
  • 批准号:
    23H01824
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
  • 批准号:
    23K06723
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
  • 批准号:
    23K14019
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
  • 批准号:
    10681898
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Cytokine Regulation of Secondary Neural Progenitors
次级神经祖细胞的细胞因子调节
  • 批准号:
    10752901
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
  • 批准号:
    10760626
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of Coccidioides Cytokine Release Assay
球孢子菌细胞因子释放测定的发展
  • 批准号:
    10760131
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Generating a novel conditional knockout mouse for a super-enhancer that controls cytokine responsiveness
生成一种新型条件敲除小鼠,用于控制细胞因子反应的超级增强子
  • 批准号:
    10740932
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
Cytokine receptor common beta chain alterations in mediastinal lymphomas
纵隔淋巴瘤细胞因子受体常见β链改变
  • 批准号:
    489197
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了